Additionally, we determined that systemic administration of FPP improved glucose intolerance in HFD-induced obese WT mice (Figure 4G), an effect that is mediated through stimulation of insulin secretion (Figure 4H). The gene discussed is INS; the disease is Glucose intolerance.